To find which dose of drug provides better pain relief for patients during delivery.
Phase 1
- Conditions
- Health Condition 1: null- Women in first stage of labour
- Registration Number
- CTRI/2018/07/014978
- Lead Sponsor
- Varghese zacharia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1Patients of ASA (American society of anaesthesiologist) physical status 1 & 2
2Between ages of 18 & 35 years
3Height in cm between 140-170cm.
Exclusion Criteria
1any co morbidities which is uncontrolled (hypertension, diabetes, hypo or hyperthyroidism)
2spine deformity
3patients with indications for caesarean section(like cephalopelvic disproportionate, fetal distress,previous caesarean section,failed induction)
4patient who receive any other form of analgesia
5Patients on any drugs like anticoagulants, antiplatelets.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To compare adequacy of analgesia in parturients receiving labour epidural with 0.15% and 0.2% ropivacaine during first and second stage of labour, by assessing analgesia using visual analogue score at 15 minutes after epidural catheterization.Timepoint: 1.To compare adequacy of analgesia in parturients receiving labour epidural with 0.15% and 0.2% ropivacaine during first and second stage of labour, by assessing analgesia using visual analogue score at 15 minutes after epidural catheterization.
- Secondary Outcome Measures
Name Time Method 1.To assess the time taken for the onset of analgesia in women receiving labour analgesia with ropivacaine (0.15% and 0.2%): <br/ ><br>2.To assess the incidence of motor blockade, incidence of instrumental delivery & caesarean section in the above population. <br/ ><br>Timepoint: 1.within first 10 minutes <br/ ><br>2.at the end of study <br/ ><br>